Renal Cancer - Results from #3400

Immunohistochemical expression of renin is a prognostic factor for recurrence in nonmetastatic renal cell carcinoma. September 4, 2019

Conditional Survival in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab. September 2, 2019

Unmarried Status is A Barrier for Access to Treatment in Patients with Metastatic Renal Cell Carcinoma September 2, 2019

Role of PDL1 as a prognostic marker in renal cell carcinoma: a prospective observational study in eastern India. August 28, 2019

Procollagen-lysine, 2-oxoglutarate 5-dioxygenases 1, 2, and 3 are potential prognostic indicators in patients with clear cell renal cell carcinoma. August 28, 2019

Comparing oncologic outcomes in patients undergoing surgery for oncocytic neoplasms, conventional oncocytoma, and chromophobe renal cell carcinoma. August 28, 2019

The Changing Therapeutic Landscape of Metastatic Renal Cancer. August 28, 2019

MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma. August 28, 2019

Systematic Review and Pooled Analysis of the Impact of Renorrhaphy Techniques on Renal Functional Outcome After Partial Nephrectomy. August 27, 2019

Hypertension and Cardiovascular Morbidity Following Surgery for Kidney Cancer. August 27, 2019

Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors. August 27, 2019

Poor Outcomes with the Use of Checkpoint Inhibitors in Kidney Transplant Recipients. August 27, 2019

Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial. August 26, 2019

Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium. August 26, 2019

Decreased expression of SLC16A12 mRNA predicts poor prognosis of patients with clear cell renal cell carcinoma. August 26, 2019

First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium. August 26, 2019

First-in-human in vivo non-invasive assessment of intra-tumoral metabolic heterogeneity in renal cell carcinoma. August 23, 2019

Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study. August 23, 2019

Value of Partial Nephrectomy for Renal Cortical Tumors of cT2 or Greater Stage: A Risk-benefit Analysis of Renal Function Preservation Versus Increased Postoperative Morbidity. August 23, 2019

Role of leptin as a biomarker for early detection of renal cell carcinoma? No evidence from a systematic review and meta-analysis. August 22, 2019

Page 171 of 459